Hsiu-Tzu Wang

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Li‐Yuan Bai · 3 shared papers, 2023–2026 · strength 0.70
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
   • Paper Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer DOI 10.1016/j.jfma.2023.01.012↗
2. Wen‐Chi Chou · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
3. Yung‐Yeh Su · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
4. Tai‐Jan Chiu · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
5. I‐Wei Ho · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
6. Chung‐Pin Li · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
7. Shih‐Hung Yang · 2 shared papers, 2026 · strength 0.50
   • Paper Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective mul… DOI 10.1016/j.jfma.2026.04.039↗
   • Paper Response to Comment on "Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcin… DOI 10.1016/j.jfma.2026.05.008↗
8. Po‐Ren Hsueh · 1 shared paper, 2023 · strength 0.20
   • Paper Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer DOI 10.1016/j.jfma.2023.01.012↗
9. Der‐Yang Cho · 1 shared paper, 2023 · strength 0.20
   • Paper Circulating tumor cells positivity provides an early detection of recurrence of pancreatic cancer DOI 10.1016/j.jfma.2023.01.012↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.